Chapurlat RD - Search Results

1

A meta-analysis of the association of fracture risk and body mass index in women.

Johansson H, Kanis JA, Odén A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S, Glüer CC, Goltzman D, Hans D, Khaw KT, Krieg MA, Kröger H, LaCroix AZ, Lau E, Leslie WD, Mellström D, Melton LJ 3rd, O'Neill TW, Pasco JA, Prior JC, Reid DM, Rivadeneira F, van Staa T, Yoshimura N, Zillikens MC. Johansson H, et al. Among authors: chapurlat rd. J Bone Miner Res. 2014 Jan;29(1):223-33. doi: 10.1002/jbmr.2017. J Bone Miner Res. 2014. PMID: 23775829 Free article.

2

Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.

Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Chapurlat RD, et al. J Bone Miner Res. 1997 Oct;12(10):1746-52. doi: 10.1359/jbmr.1997.12.10.1746. J Bone Miner Res. 1997. PMID: 9333137 Free article. Clinical Trial.

3

Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.

Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD. Chapurlat RD, et al. J Bone Miner Res. 2000 Sep;15(9):1835-41. doi: 10.1359/jbmr.2000.15.9.1835. J Bone Miner Res. 2000. PMID: 10977003 Free article.

4

What PROOF proves about calcitonin and clinical trials.

Cummings SR, Chapurlat RD. Cummings SR, et al. Among authors: chapurlat rd. Am J Med. 2000 Sep;109(4):330-1. doi: 10.1016/s0002-9343(00)00539-8. Am J Med. 2000. PMID: 10996586 No abstract available.

5

Influence of smoking on the antiosteoporotic efficacy of raloxifene.

Chapurlat RD, Ewing SK, Bauer DC, Cummings SR. Chapurlat RD, et al. J Clin Endocrinol Metab. 2001 Sep;86(9):4178-82. doi: 10.1210/jcem.86.9.7848. J Clin Endocrinol Metab. 2001. PMID: 11549646 Clinical Trial.

6

Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: study of osteoporotic fractures.

Chapurlat RD, Bauer DC, Cummings SR. Chapurlat RD, et al. Bone. 2001 Oct;29(4):381-7. doi: 10.1016/s8756-3282(01)00584-1. Bone. 2001. PMID: 11595622

7

Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness?

Chapurlat RD, Cummings SR. Chapurlat RD, et al. Osteoporos Int. 2002 Sep;13(9):738-44. doi: 10.1007/s001980200101. Osteoporos Int. 2002. PMID: 12195538

8

Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures.

Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR. Chapurlat RD, et al. Osteoporos Int. 2003 Apr;14(2):130-6. doi: 10.1007/s00198-002-1327-6. Epub 2003 Feb 13. Osteoporos Int. 2003. PMID: 12730779

9

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.

Chapurlat RD, Palermo L, Ramsay P, Cummings SR. Chapurlat RD, et al. Osteoporos Int. 2005 Jul;16(7):842-8. doi: 10.1007/s00198-004-1770-7. Epub 2004 Dec 3. Osteoporos Int. 2005. PMID: 15580479 Clinical Trial.

10

Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease.

Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R. Bacchetta J, et al. J Bone Miner Res. 2010 Apr;25(4):849-57. doi: 10.1359/jbmr.090831. J Bone Miner Res. 2010. PMID: 19775204 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page